Zhao, Q.; Du, W.; Zhou, L.; Wu, J.; Zhang, X.; Wei, X.; Wang, S.; Huang, Y.; Li, Y.
Transferrin-Enabled Blood–Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke. Pharmaceutics 2022, 14, 1122.
https://doi.org/10.3390/pharmaceutics14061122
AMA Style
Zhao Q, Du W, Zhou L, Wu J, Zhang X, Wei X, Wang S, Huang Y, Li Y.
Transferrin-Enabled Blood–Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke. Pharmaceutics. 2022; 14(6):1122.
https://doi.org/10.3390/pharmaceutics14061122
Chicago/Turabian Style
Zhao, Qianqian, Wenxian Du, Lingling Zhou, Jianrong Wu, Xiaoxing Zhang, Xiaoer Wei, Sijia Wang, Yu Huang, and Yuehua Li.
2022. "Transferrin-Enabled Blood–Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke" Pharmaceutics 14, no. 6: 1122.
https://doi.org/10.3390/pharmaceutics14061122
APA Style
Zhao, Q., Du, W., Zhou, L., Wu, J., Zhang, X., Wei, X., Wang, S., Huang, Y., & Li, Y.
(2022). Transferrin-Enabled Blood–Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke. Pharmaceutics, 14(6), 1122.
https://doi.org/10.3390/pharmaceutics14061122